Senate Medicare Rx Work Begins; Merck Joins In Frist Briefing
Executive Summary
Merck is playing a key role in the preliminary Medicare legislative drafting effort in the Senate
You may also be interested in...
GSK Remains Positive On Medicare Rx, Outcome Of AWP Suit
GlaxoSmithKline continues to see only an upside from the potential creation of a Medicare prescription drug benefit, Pharmaceutical Operations President David Stout told investors in New York City Feb. 13
GSK Remains Positive On Medicare Rx, Outcome Of AWP Suit
GlaxoSmithKline continues to see only an upside from the potential creation of a Medicare prescription drug benefit, Pharmaceutical Operations President David Stout told investors in New York City Feb. 13
Medicare Rx Hinges On Senate Finance Cmte.; White House Delays Details
The prospects for a Medicare drug benefit in 2003 are likely to hinge on the ability of the Senate Finance Committee to find a bipartisan consensus over the next several months